Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Manufactures and sells pharmaceuticals

Puratos NV manufactures and supplies ingredients to the bakery, patisserie, and chocolate sectors. Its products include specialty bread mixes, emulsifiers, yeast, cakes, fruit and cream fillings, chocolate and nut fillings, and decoration solutions. The firm also offers recipes, flavoring preparations, glazes, icing, fudge, ganache and non-dairy toppings. The company was founded on September 28, 1989 and is headquartered in Groot-Bijgaarden, Belgium.

Yissum is the technology transfer company of The Hebrew University of Jerusalem. Founded in 1964, it is the 3rd company of its kind ever created, and has a rich tradition of innovation and commercialization. Through our efforts to identify and create breakthrough scientific research at Hebrew University, we aspire to advance commercial solutions to the most pressing global challenges facing humanity. (Contact Tamir Huberman) Some of our well-known spin-off companies include Mobileye, Orcam, Collplant, Qlight, and Briefcam. Yissum’s business partners span the globe and include companies such as Novartis, Johnson & Johnson, Merck, Intel, Google, Boston Scientific, ICL and many more. Since its inception, Yissum has registered 10,000+ patents covering 2,800+ inventions; licensed 900 technologies and produced 130+ spin-off companies.

AAK publ AB, also known as AarhusKarlshamn publ AB, is a Sweden-based holding company active primarily in the food processing sector. The Company refines vegetable oils for specialized products. The Company is organized, along with its subsidiaries, into three business segments: the Food Ingredients segment includes baking fat, dairy fat alternatives, Ice cream fats, infant formulas and oil/fats ingredients, among others; the Chocolate & Confectionery Fats segment provides chocolate and confectionery advantages, ranging from products developed for better sensory, health and longer shelf life to cost efficiency, know-how, technology and service, and the Technical Products & Feed segment includes golden wax, fatty acids, glycerin, deinking chemicals and animal feed.

Enzymotec is a biotechnology company that develops and produces biofunctional ingredients to address health needs associated with the human life cycle, starting from babies up to seniors.

Nanjing Luye Pharmaceutical Co., Ltd., established on 2002-02-22, The business scope includes freeze-dried powder injection,Freeze-dried powder injection(anticancer drug),powder injection,Sterile API(Amifostine),API(Lentinan,Bupropion Hydrochloride,Selegiline Hydrochloride,Pamidronate disodium),medical supplements(egg yolk lecithin,Distearoylphosphatidylcholine,cultured phosphatidylethanolamine,cholesterol),small volume injection(anticancer drug,non-terminal sterilized),Class II6863Production of dental materials;Sell ​​self-produced products;drug development.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:Medical Research and Experimental Development(remove human stem cells,Development and application of genetic diagnosis and treatment technology);Business Management Consulting;Corporate Image Planning;marketing planning;market survey(Does not include foreign investigations);Professional Design Services;brand management;Consulting and planning service;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Nanjing Kanghai Phospholipid Biotechnology Co., Ltd., established on 2010-09-13, Business scope includes research and development of phospholipid technology,Technical consulting and technical services and product sales;drug development.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Ecovatec Solutions Inc is a food technology company who has developed several novel high value ingredients with the potential to treat a number of health conditions such as anemia, osteoporosis, eczema, psoriasis, and heart disease to name a few, all extracted and purified from simple pure egg yolk.

Société des Produits Nestlé SA engages in the manufacture and distribution of food, pharmaceutical, medical, and cosmetic products. The company was founded on December 15, 1936 and is headquartered in Vevey, France.

Vectura Ltd., part of Philip Morris International, Inc., is a British company located in Chippenham. The firm manufactures medical equipment. It was founded in 1983.\nThe company says this about itself: The principal activity of the Company is that of research, development and commercialisation of pharmaceutical products and technologies and this is expected to continue for the foreseeable future. Vectura Limited (the \"Company\") is a wholly-owned subsidiary of Vectura Group plc (\"Vectura\" or the \"Group\") which is the smallest and largest entity to consolidate the Company's results. The Company's immediate parent undertaking is Vectura Group Investments Limited.

Nuokangda Pharmaceutical Technology provides product upgrade and technology development services for pharmaceutical companies. It engages in research and development activities related to pharmaceuticals, accessories, medical equipment and supplies, and other pharmaceutical-related areas

Beijing Deli Furui Pharmaceutical Technology Co., Ltd., established on 2010-12-31, Business scope includes technology promotion,technical consulting,technology development,technology transfer;Conference Services;Economic and Trade Consulting;marketing planning;Organize cultural and artistic exchanges;Undertake the exhibition;Sales of chemical products(Free of Hazardous Chemicals),daily necessities,stationery,sporting goods.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

NeXstar Pharmaceuticals, Inc. was a commercial biopharmaceutical\ncompany engaged in the discovery, development, manufacture and marketing of\nproprietary pharmaceutical products to treat life-threatening and other\nserious diseases. The firm was located in Boulder, CO.

Vestar, Inc., a subsidiary of Advanced Micro Devices, Inc., is an American company located in San Dimas, CA, involved in pharmaceutical preparations. Nexgen, Inc. acquired Vestar, Inc. on February 22, 1995 for $96.70 million.

Indena is the world’s leading company in the identification, development and production of active principles derived from plants, for use in the pharmaceutical, health-food and personal care industries.Indena, a privately owned Italian company, has around 800 employees (10% of them dedicated to full-time research) and has cultivation, manufacturing, and sales in more than 70 countries throughout the world.

Part of CSPC Pharmaceutical Group Ltd., CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co., Ltd. is a company headquartered in China. The firm engages in pharmaceutical research and development.

Tianjin Guanqin Pharmaceutical Technology Co., Ltd. engages in the provision of preclinical and clinical services. It offers pre-clinical research, clinical research, third-party audits, pharmacovigilance, and other technical services in the drug development process. The company was founded on November 28, 2007 and is headquartered in Tianjin, China.

Xiangxue Pharmaceutical Co., Ltd. develops pharmaceutical products, Chinese herbal compound medicine, biomedical engineering product, functional drink, healthy food and herbal planting. Its products include more than 80 kinds of medicine, which fall into four categories of oral liquid, tablet, capsule and pellet. The company was founded by Wang Yonghui on December 16, 1997 and is headquartered in Guangzhou, China.